chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 42.0
Sex: U
Vaccine: HEP
Symptoms: Burning sensation, Inappropriate schedule of product administration
Clinical narrative: Dose 2 given two days after dose 1; Burning Sensation In Arm With Second Injection; Initial report received on 25-Jun-2024.  A pharmacist reported that a 42-year-old female (race and ethnicity not provided) received the first dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization and received the second dose two days later, then experienced a burning sensation in the arm.  The patient has no allergies.  No relevant concomitant medications were reported.    On 20-Jun-2024, the patient received the first dose of HEPLISAV-B (Lot #944914, expiration date 05-Sep-2026, NDC # 43528-003-05, route and site not reported).  On 22-Jun-2024, the patient received the second dose of HEPLISAV-B (Lot #944914, expiration date 05-Sep-2026, NDC # 43528-003-05, route and site not reported) and experienced a burning sensation in the arm.    No other reactions were reported.   It is unknown if the event of burning sensation had resolved.  No additional information was provided.   Company Comment: The company assessed the events as non-serious.; Sender's Comments: The company assessed the events as non-serious.
Age: 27.0
Sex: U
Vaccine: HEP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Received First Dose July 2023, Received Second Dose July 2024; Initial report received on 09-Jul-2024.  A pharmacist reported that a 28-year-old male (race and ethnicity not provided) received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization and has not received second scheduled dose.  No relevant medical history and no relevant concomitant medications were reported. No known allergies reported.  On 14-Jul-2023, the patient received the first dose of HEPLISAV-B (lot number, expiration date, NDC number, route and site not reported). On 09-Jul-2024, 11 months and 26 days after receiving the initial dose, the patient received the second dose of HEPLISAV-B (lot number 945139, expiration date 22-Jan-2026, and NDC number 43528-0003-05) intramuscularly in the left deltoid.  No further information was available.    Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
Age: 13.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Extra dose administered
Clinical narrative: The provider changed the vaccine order and did not let the MA know about the changes, patient received extra doses of TDAP and MenQuadfi.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Myalgia
Clinical narrative: Severe muscle and joint pain x 3-4 days., advised Dr the 4th day
Age: 59.0
Sex: F
Vaccine: PNC20
Symptoms: Arthralgia, Erythema, Fatigue, Peripheral swelling, Pyrexia
Clinical narrative: Patient came to pharmacy 7/17/24 stating the immunization she received on 7/3/24, Prevnar 20, caused her arm to get swollen, red and tender. She stated her joints ached, she was very tired and she had a fever. Her symptoms lasted approximately 3 days.
Age: 59.0
Sex: F
Vaccine: PNC20
Symptoms: Tenderness
Clinical narrative: Patient came to pharmacy 7/17/24 stating the immunization she received on 7/3/24, Prevnar 20, caused her arm to get swollen, red and tender. She stated her joints ached, she was very tired and she had a fever. Her symptoms lasted approximately 3 days.
Age: 51.0
Sex: M
Vaccine: VARZOS
Symptoms: Blister, Rash, Rash erythematous
Clinical narrative: red blistered rash that appeared to be spreading back the back of the patient's left arm
Sex: M
Vaccine: DTPPVHBHPB, PNC15
Symptoms: Swelling, Wheezing
Clinical narrative: Patient came in 07-16-2024. For swelling and wheezing.
Age: 11.0
Sex: F
Vaccine: TDAP
Symptoms: Erythema, Pruritus, Swelling, Tenderness
Clinical narrative: Swelling, tenderness, redness and itching. Pt was prescribed benadryl and triamcinolone topical cream
Age: 17.0
Sex: M
Vaccine: MENB
Symptoms: Headache, Injection site erythema, Injection site pain, Injection site swelling, Pain
Clinical narrative: Redness and swelling at the injection site. Soreness to touch at the site and soreness when raising his arm. Periodic headaches for two days following injection. All other symptoms lasted for three days following injection.
Age: 24.0
Sex: M
Vaccine: PNC20
Symptoms: Wrong product administered
Clinical narrative: pt was suppose to be given a TDAP and PCV20 was given instead.
Age: 34.0
Sex: F
Vaccine: TDAP
Symptoms: Exposure during pregnancy
Clinical narrative: Pt was unknowingly pregnant during time of vaccination, as of 17JUL2024 pt is 3 weeks 3 days pregnant.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Headache, Malaise, Myalgia, Nausea, Vomiting
Clinical narrative: Patient woke up and felt nauseous and threw up. Patient was also having muscle aches and headaches. Patient did not feel well. Reporting mainly for the vomiting
Age: 24.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Fatigue, Injection site pruritus, Local reaction, Lymphangitis, Vaccination site erythema
Clinical narrative: Local reaction at vaccination site with erythema, warmth, induration, and itching.   17 x 9 cm area.  Lymphangitis with streaking measuring 15cm.  Fatigue.
Age: 24.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Vaccination site induration, Vaccination site warmth
Clinical narrative: Local reaction at vaccination site with erythema, warmth, induration, and itching.   17 x 9 cm area.  Lymphangitis with streaking measuring 15cm.  Fatigue.
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Received vaccine on 06/21/2024 by 06/25/2024 I had developed shingles on the left side of my body/ trunk and left breast
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Balance disorder, Heart rate increased, Immediate post-injection reaction, Loss of libido
Clinical narrative: Pt states they immediate had racing HR (130bpm) (unknown how this was confirmed). then developed neurologic symptoms including: tinnitus, loss of balance, neuropathy, full body resting tremors, frozen shoulder, joint pain, postural orthostatic tachycardia syndrome, complete loss of libido. Pt did not disclose what medical treatments was sought or when each symptom occurred.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Neurological symptom, Neuropathy peripheral, Palpitations, Periarthritis, Postural orthostatic tachycardia syndrome
Clinical narrative: Pt states they immediate had racing HR (130bpm) (unknown how this was confirmed). then developed neurologic symptoms including: tinnitus, loss of balance, neuropathy, full body resting tremors, frozen shoulder, joint pain, postural orthostatic tachycardia syndrome, complete loss of libido. Pt did not disclose what medical treatments was sought or when each symptom occurred.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Resting tremor, Tinnitus
Clinical narrative: Pt states they immediate had racing HR (130bpm) (unknown how this was confirmed). then developed neurologic symptoms including: tinnitus, loss of balance, neuropathy, full body resting tremors, frozen shoulder, joint pain, postural orthostatic tachycardia syndrome, complete loss of libido. Pt did not disclose what medical treatments was sought or when each symptom occurred.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain in extremity, Ultrasound lymph nodes
Clinical narrative: Enlarged lymph nodes and pain in arm for 3 years starting one day after vaccine . I need ultrasounds every 6 months
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Antibody test, Antibody test abnormal
Clinical narrative: Headache; This is a spontaneous report received from a Consumer or other non HCP.  A 48-year-old male patient received BNT162b2 (BNT162B2), on 15May2021 as dose 1, single (Lot number: EW0182) at the age of 48 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: HEADACHE (non-serious), outcome "unknown".
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache
Clinical narrative: Headache; This is a spontaneous report received from a Consumer or other non HCP.  A 48-year-old male patient received BNT162b2 (BNT162B2), on 15May2021 as dose 1, single (Lot number: EW0182) at the age of 48 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: HEADACHE (non-serious), outcome "unknown".
Age: 1.5
Sex: U
Vaccine: HEPA
Symptoms: No adverse event, Product storage error
Clinical narrative: No adverse effects noted. No other information provided; HCP reports patient received improperly stored VAQTA.; This spontaneous report was received from an Medical Assistant and referred to an 18-month-old patient of unknown gender. The patient's concurrent conditions, concomitant therapies, historical drugs and historical conditions were not reported.  On an unknown date, hepatitis a vaccine, inactivated (VAQTA) intramuscular injection (lot #X025482, expiration date: 12-APR-2025, strength was not reported) experienced temperature excursion (TE) with 34.5 degree Fahrenheit (F) for 82 Hours 50 Minutes. No Previous TE. On 24-JUN-2024, the patient was vaccinated with improper stored hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, single dose, lot #X025482, expiration date: 12-APR-2025, administered for prophylaxis (strength, anatomical site of administration and route of administration were not provided) (Product storage error). No adverse effects noted. No other information provided (no adverse event).
Sex: U
Vaccine: VARCEL
Symptoms: No adverse event, Product storage error
Clinical narrative: No PQC/additional AE; a dose of vaccine was administered on 25JUN2024 after it experienced a temperature excursion; This spontaneous report was received from an office manager referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies, drug reactions and allergies were not reported.    On 25-JUN-2024, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (lot # X010531, expiration date: 11-APR-2025; strength, dose, anatomical location and route of administration were not provided) for prophylaxis. It was reported that the suspect vaccine was underwent temperature excursions of 6 degree Fahrenheit (F) to 14 degree F (the time frame was 45 minutes) (product storage error). There were no previous temperature excursions. No additional adverse event (AE) was reported (no adverse event).
Sex: M
Vaccine: RSV
Symptoms: Extra dose administered
Clinical narrative: Two doses administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a male patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   Previously administered products included AREXVY.   On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced extra dose administered (Verbatim: Two doses administered). The outcome of the extra dose administered was unknown.   Additional Information: GSK Receipt Date: 08-JUL-2024 The patient had two respiratory syncytial virus vaccinations within the year from Arexvy, one was administered at their clinic and another one at a pharmacy, which led extra dose administered.  The reporter consented to follow up.
Age: 23.0
Sex: F
Vaccine: HEP
Symptoms: Underdose
Clinical narrative: Pediatric dose to an adult; underdose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of adult use of a child product in a 23-year-old female patient who received HBV (Engerix B pediatric) (batch number 32M5G, expiry date 14-SEP-2025) for prophylaxis.   On 06-JUL-2024, the patient received the 3rd dose of Engerix B pediatric. On 06-JUL-2024, an unknown time after receiving Engerix B pediatric, the patient experienced adult use of a child product (Verbatim: Pediatric dose to an adult) and underdose (Verbatim: underdose). The outcome of the adult use of a child product and underdose were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 08-JUL-2024 The reporter reported the patient were administrated the Engerix-B pediatric dose, that were over the age of 20, which led adult use of a child product and underdose. This case was linked with US2024084974 for the same reporter.; Sender's Comments:  US-GSK-US2024084974:Same reporter/different patient
Age: 0.08
Sex: F
Vaccine: HIBV
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: inappropriate use due to administering ACTHIB 3rd dose earlier than intended with no reported adverse event; 1st dose in the series was administered earlier than approved age indication with no reported adverse event; Initial information received on 16-Jul-2024 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 7 weeks old female patient to whom 1st dose in the series was administered earlier than approved age indication and inappropriate use due to administering HIB (PRP/T) vaccine [ACT-HIB] 3rd dose earlier than intended with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included POLIO VACCINE INACT (IPV) and DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (DTAP) for Immunisation.  On 13-Nov-2023, the patient 1st dose in the series was administered at age of 1 month and 20 days of suspect HIB (PRP/T) VACCINE, Powder and solvent for solution for injection (dose, lot number and expiry date not reported) via unknown route in unknown administration site for Immunization earlier than approved age indication with no reported adverse event (product administered to patient of inappropriate age) (latency: same day)  On 12-Apr-2024, the patient received unknown dose (dose 2) at 6 months of same vaccine (lot number and expiry date not reported) via unknown route in unknown administration site for Immunization.  On 15-Jul-2024 she also received 0.5 ml (dose 3) at age of 9 months of same vaccine (lot; UJ992AA: Expiration date: 28-Feb-2025) via intramuscular route in the right thigh for Immunization earlier than intended with no reported adverse event (inappropriate schedule of product administration) (latency: same day) last dose of HIB (PRP/T) VACCINE.    This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Eye irritation, Hypertension, Hypotension, Lacrimation increased
Clinical narrative: Burning eyes, painful, watery , hypotension, dizziness, hypertension
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: DEATH
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: Office manager confirmed that patient has not reported any other AEs since administration/No additional AE; Office manager reported that a dose of vaccine was administered on 27JUN2024 after it experienced a temperature excursion on 24JUN2024.; This spontaneous report was received from an office manager and referred to a patient of unknown age and gender. The patient's concurrent conditions, concomitant therapies, historical drugs and historical conditions were not reported.  On 24-JUN-2024, measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant Human albumin [rHA]) (PROQUAD) injection (lot #X023875, expiration date: 27-MAR-2025, strength was not reported) experienced a temperature excursion (TE) with 6 degree Fahrenheit (F) to 14 F (13.92 F) for 45 minutes. No previous temperature excursion. On 27-JUN-2024, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) injection (1 dose, lot #X023875, expiration date: 27-MAR-2025, administered for prophylaxis, strength, exact dose, anatomical site of administration and route of administration were not provided) (Product storage error). Office manager confirmed that patient had not reported any other adverse events (AEs) since administration. No additional AE (no AE).
Age: 22.0
Sex: M
Vaccine: HEP
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: got the pediatric dose of hepatitis B vaccine instead of the adult product; got the pediatric dose of hepatitis B vaccine instead of the adult product; This non-serious case was reported by a other health professional via call center representative and described the occurrence of underdose in a 22-year-old male patient who received HBV (Engerix B pediatric) (batch number 42B22, expiry date 07-MAR-2026) for prophylaxis.   On 05-JUL-2024, the patient received the 1st dose of Engerix B pediatric (intramuscular, right deltoid) .5 ml. On 05-JUL-2024, an unknown time after receiving Engerix B pediatric, the patient experienced underdose (Verbatim: got the pediatric dose of hepatitis B vaccine instead of the adult product) and adult use of a child product (Verbatim: got the pediatric dose of hepatitis B vaccine instead of the adult product). The outcome of the underdose and adult use of a child product were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 08-JUL-2024 The reporter was a certified medical assistant. There was an incident where a patient got the pediatric dose of hepatitis B (Engerix-B 10mcg) vaccine instead of the adult product/dose (20 mcg/mL), which led to underdose and adult use of a child product.
Age: 4.0
Sex: F
Vaccine: HPV9
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: No symptoms were reported.  No additional AEs; GARDASIL 9 was administered to her 4 year old daughter; This spontaneous report was received from a Consumer and referred to a 4-year-old female patient.  The patient's medical history, concurrent conditions, concomitant therapies, drug reactions and allergies were not reported.  On 01-JUL-2024 (at the age of 4 years old), the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, administered for prophylaxis (strength, dose, lot #, expiry date, and route of administration were not provided) (Product administered to patient of inappropriate age). No additional AE.  Lot # is being requested and will be submitted if received.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Angioedema, Erythema, Hypersensitivity, Pharyngeal swelling, Pruritus
Clinical narrative: 4-17-21 - ER - Came in with localized swelling, itching, redness of skin. Symptoms/episodes began/occurred acutly. Rash can be described as erythematous. Order Dexamethasone solution phosphate 4 mg./IM once DEPO-MEDROL - DEPO-MEDROL 40 mg. once 4-18-21 - ER - itching localized swelling, rash onset hives, patient has treated with Benadryl. Facial swelling, hive like onset yesterday. Returned to ER due to increased swelling of the other side of face & mild swelling of throat. Benadryl 25mg., Decadron 4mg. Return to ER if symptoms worsen or persist. Allergic reaction with associated rash and Angioedema Prednisone 20 mg   ER 4-23-21 patinet presents itching, rash, redness of skin. Pertinent positives hives, rash, symptoms are unchanged and worse. Skin rash can be described as erythematous, macular, nonspecific. Diagnosis-allergic urticaria, follow up with provider. Allergies epinephrine injection hives, angioedema. Meds prednisone 10mg oral 4-28-2021  Provider  symptoms includes itching raised wheals while symptoms do not include angioedema. Urticaria are located on the neck, arm trunk, face, lets. The symptoms occur constantly  fair tolerance of treatment and poor symptom control. She dropped 20mg of prednisone and it has exacerbated. (large diffuse areas of whelps) Assessment & plan 4-28-21 -  acute urticaria (L50.8) Impression need to see allergist ASAP. Will have to go back up on prednisone. She understands sxs of anaphylaxis and to use epi-pen in that event. Pt. go to allergist today! Current plans Methylprednisolone acetate 80mg (J1040) name brand DEPO-MEDROL (IM/gm w/o diff. NDC Ther/proph/diag inj. SC/IM (96372) Started hydroxyzine HCl 25mg 4 to 6 hrs. Started Epipen 2 pack 0.3 ml injection 4-28-21 4-26-21 female 57 yrs. old, with acute urticaria symptoms include itching, raised red wheals and angioedema. Urticaria are located on face, neck, arm, trunk, legs. Associated with hoarseness while symptoms do not include dyspnea. She was seen in the ER three times. She had the Moderna vaccine 10 days before first episode. She is currently on 30mg prednisone. She is not feeling well on the high dose of steroids. She is not taking meloxicam and stopped her trazodone to be safe. Restarted loratadine 10mg oral 1 dy. started 4-26-21 x5 refills Started montelukast sodium 10mg oral 1x dy. No refill Referred to allergy immunology for opinion & treatment faxed
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Swelling, Swelling face, Urticaria
Clinical narrative: 4-17-21 - ER - Came in with localized swelling, itching, redness of skin. Symptoms/episodes began/occurred acutly. Rash can be described as erythematous. Order Dexamethasone solution phosphate 4 mg./IM once DEPO-MEDROL - DEPO-MEDROL 40 mg. once 4-18-21 - ER - itching localized swelling, rash onset hives, patient has treated with Benadryl. Facial swelling, hive like onset yesterday. Returned to ER due to increased swelling of the other side of face & mild swelling of throat. Benadryl 25mg., Decadron 4mg. Return to ER if symptoms worsen or persist. Allergic reaction with associated rash and Angioedema Prednisone 20 mg   ER 4-23-21 patinet presents itching, rash, redness of skin. Pertinent positives hives, rash, symptoms are unchanged and worse. Skin rash can be described as erythematous, macular, nonspecific. Diagnosis-allergic urticaria, follow up with provider. Allergies epinephrine injection hives, angioedema. Meds prednisone 10mg oral 4-28-2021  Provider  symptoms includes itching raised wheals while symptoms do not include angioedema. Urticaria are located on the neck, arm trunk, face, lets. The symptoms occur constantly  fair tolerance of treatment and poor symptom control. She dropped 20mg of prednisone and it has exacerbated. (large diffuse areas of whelps) Assessment & plan 4-28-21 -  acute urticaria (L50.8) Impression need to see allergist ASAP. Will have to go back up on prednisone. She understands sxs of anaphylaxis and to use epi-pen in that event. Pt. go to allergist today! Current plans Methylprednisolone acetate 80mg (J1040) name brand DEPO-MEDROL (IM/gm w/o diff. NDC Ther/proph/diag inj. SC/IM (96372) Started hydroxyzine HCl 25mg 4 to 6 hrs. Started Epipen 2 pack 0.3 ml injection 4-28-21 4-26-21 female 57 yrs. old, with acute urticaria symptoms include itching, raised red wheals and angioedema. Urticaria are located on face, neck, arm, trunk, legs. Associated with hoarseness while symptoms do not include dyspnea. She was seen in the ER three times. She had the Moderna vaccine 10 days before first episode. She is currently on 30mg prednisone. She is not feeling well on the high dose of steroids. She is not taking meloxicam and stopped her trazodone to be safe. Restarted loratadine 10mg oral 1 dy. started 4-26-21 x5 refills Started montelukast sodium 10mg oral 1x dy. No refill Referred to allergy immunology for opinion & treatment faxed
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Injection site induration, Injection site pain, Injection site reaction, Injection site swelling, Livedo reticularis
Clinical narrative: In the arm with the Meningococcal vaccination, the site around the vaccine got really hard, and he said it hurt. It was swollen, too (which explains why it was hard), and it looked like he was a body builder in one arm! The area was blotchy and mottled in a 4" x 4" area.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Rash macular
Clinical narrative: In the arm with the Meningococcal vaccination, the site around the vaccine got really hard, and he said it hurt. It was swollen, too (which explains why it was hard), and it looked like he was a body builder in one arm! The area was blotchy and mottled in a 4" x 4" area.
Age: 47.0
Sex: M
Vaccine: HEPAB
Symptoms: Hepatitis B antibody negative, Therapy non-responder
Clinical narrative: Lost immunity.  Facility blood test in July 2024 confirmed that I do not have immunity to Hepatitus B despite having received the 3-dose Trinrix vaccine in 2006-2007.  I do have immunity to Hepatitus A.  The Facility is recommending that I be revaccinated for Hepatitus B.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, Death
Clinical narrative: My mother received the COVID19 vaccine on10/27/23 and died two days later in her sleep. Her doctor said she was an otherwise healthy 74 year old women, she did not know how to explain her death. But her doctor also did not take our concerns seriously when we raised questions about her being vaccinated just two days before being found dead.
Age: 59.0
Sex: M
Vaccine: TDAP
Symptoms: Extra dose administered, Wrong product administered
Clinical narrative: Patient was meant to be given Twinrix, but the Tdap was given in error.  Patient had a Tdap vaccine 7/12/23 previously.
Age: 21.0
Sex: F
Vaccine: TDAP
Symptoms: Asthenia, Seizure, Syncope, Tremor, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Mild, Systemic: Seizure-Mild, Systemic: Shakiness-Mild, Systemic: Weakness-Mild
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Injected limb mobility decreased, Injection site pain
Clinical narrative: Site: Pain at Injection Site-Severe, Additional Details: Patient received both her Shingrix and Moderna vaccine in left arm on 6/27/24.  Patient called 7/8/24 stating she has not been able to lift her arm since.  I asked where the pain was located and she stated where the injections were given mid arm (not in her shoulder area).  I advised her to take some ibuprofen  and to see her PCP if pain continues., Other Vaccines:  VaccineTypeBrand: Spivevax Covid; Manufacturer: Moderna; LotNumber: 207H23A; Route: IM; BodySite: Left arm; Dose: 1; VaxDate: 06/27/2024
Age: 26.0
Sex: F
Vaccine: MMR
Symptoms: Fall, Head injury, Loss of consciousness
Clinical narrative: Systemic: Fainting / Unresponsive-Mild, Additional Details: Prior to giving patient vaccine,she told me she had previously passed out. After giving the vaccine she said she was fine. She walked over to register then said she better sit down. After she sat down, she passed out temporatirly. She bumped her hed on partion as she was falling to her knees., Other Vaccines:  VaccineTypeBrand: Heplisav b; Manufacturer: Dynavax; LotNumber: 944918; Route: im; BodySite: left arm; Dose: 1; VaxDate: 07/08/2024
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium
Age: 23.0
Sex: M
Vaccine: MMR
Symptoms: Dizziness, Hyperhidrosis, Nausea, Vomiting
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Nausea-Medium, Systemic: Vomiting-Mild, Additional Details: Patient experienced dizziness and nausea approximately 5 minutes after receiving vaccine. He was sweating and vomited. Blood pressure was taken 140/80 which patient stated was normal for him. Patient stayed seated in vaccination area for 50 minutes until symptoms of dizziness resolved. I phoned patient an hour later and he stated his symptoms have "mostly resolved but he is somewhat nauseous". I contacted the patient's PCP to notify him of the incident.
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Headache-Medium
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Additional Details: received clindamycin from Clinic.   Condition is improving.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site bruising, Injection site erythema, Injection site pain, Injection site swelling, Pain
Clinical narrative: Site: Bruising at Injection Site-Severe, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Severe, Systemic: Fever-Medium, Additional Details: Patient reported on 07/11/24 and came in on 07/12/24 to discuss. She reports after shot (which was her 1st Pfizer, had been getting Moderna) having a fever for 2 days. Also bruising from shot area middle of deltoid (she pointed to mild deltoid and agreed that was where shot was given)  down to crease in arm (opposite of elbow). She also stated she had a gulf size bump/bruise right about crease in arm.  Bruise is now gone. But having pain when moving arm from shot spot down to about to below deltoi
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Site: Bruising at Injection Site-Severe, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Severe, Systemic: Fever-Medium, Additional Details: Patient reported on 07/11/24 and came in on 07/12/24 to discuss. She reports after shot (which was her 1st Pfizer, had been getting Moderna) having a fever for 2 days. Also bruising from shot area middle of deltoid (she pointed to mild deltoid and agreed that was where shot was given)  down to crease in arm (opposite of elbow). She also stated she had a gulf size bump/bruise right about crease in arm.  Bruise is now gone. But having pain when moving arm from shot spot down to about to below deltoi
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash, Injection site swelling, Pruritus
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash Generalized-Medium, Additional Details: rash and redness at injection site
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash Generalized-Medium, Additional Details: rash and redness at injection site
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Injection site pain, Joint injury, Limb injury, Paraesthesia
Clinical narrative: Site: Pain at Injection Site-Severe, Systemic: Joint Pain-Severe, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-, Other Vaccines:  VaccineTypeBrand: prevnar 20; Manufacturer: pfizer; LotNumber: hm0310; Route: intramuscular; BodySite: left arm; Dose: ; VaxDate: 07/01/2024
Age: 66.0
Sex: M
Vaccine: TDAP
Symptoms: Axillary pain, Lymphadenopathy, Oedema peripheral
Clinical narrative: Systemic: Lymph Node Swelling-Medium, Additional Details: Pt reports pain and swelling in axilla region, near insertion of right pectoralis muscle. He says it was more pronounced in the evening of 7/13, and some improvement seen by today (7/14)
Age: 73.0
Sex: F
Vaccine: RSV
Symptoms: Chills, Injection site bruising, Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: Site: Bruising at Injection Site-Severe, Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Chills-Severe, Systemic: Fever-Severe, Other Vaccines:  VaccineTypeBrand: boostrix; Manufacturer: Glaxosmithkline; LotNumber: KY27J; Route: im; BodySite: rightside; Dose: ; VaxDate: UNKNOWN
Age: 73.0
Sex: F
Vaccine: RSV
Symptoms: Injection site swelling, Pyrexia
Clinical narrative: Site: Bruising at Injection Site-Severe, Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Chills-Severe, Systemic: Fever-Severe, Other Vaccines:  VaccineTypeBrand: boostrix; Manufacturer: Glaxosmithkline; LotNumber: KY27J; Route: im; BodySite: rightside; Dose: ; VaxDate: UNKNOWN
Age: 92.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium
Sex: U
Vaccine: UNK
Symptoms: Product storage error
Clinical narrative: Temperature Excursion: July 17, 2024 @ 09:07 for 33 minutes.
Age: 1.0
Sex: F
Vaccine: PNC13
Symptoms: No adverse event, Product preparation issue
Clinical narrative: Patient received dose of diluent instead of being reconstituted with vaccine. Parents were made aware, and patient was scheduled to return to clinic for a repeat dose.  Patient had no side effects or adverse reaction
Age: 4.0
Sex: M
Vaccine: DTAPIPV, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: 8cm x 5 cm redness, warmth and swelling around injection site.
Age: 24.0
Sex: F
Vaccine: RAB
Symptoms: Abdominal pain, Blood pressure increased, Cough, Erythema, Feeling hot
Clinical narrative: She started out feeling itching, then her hands started turning red up to her wrists. This was followed by irritation in the throat and a flushed face. She also complained of feeling like she was on fire, throat irritation, and started coughing. By the time medication was administered, her face was mildly swollen, with hives on her back, groin area, armpits, neck, and face. Her blood pressure was elevated and she also experienced pain in her abdomen.
Age: 24.0
Sex: F
Vaccine: RAB
Symptoms: Flushing, Pruritus, Swelling face, Throat irritation, Urticaria
Clinical narrative: She started out feeling itching, then her hands started turning red up to her wrists. This was followed by irritation in the throat and a flushed face. She also complained of feeling like she was on fire, throat irritation, and started coughing. By the time medication was administered, her face was mildly swollen, with hives on her back, groin area, armpits, neck, and face. Her blood pressure was elevated and she also experienced pain in her abdomen.
Age: 1.0
Sex: M
Vaccine: HEPA, MMRV
Symptoms: Pyrexia
Clinical narrative: Parents reported fevers started within a day or so of immunizations, up to 104, and persisted for a week.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac disorder, Death
Clinical narrative: Patient died on 10/19/2023, from chronic heart disease that she did not have prior to getting the covid vaccines.
Age: 0.75
Sex: M
Vaccine: COVID19-2
Symptoms: Product preparation error
Clinical narrative: Patient was given 0.3mL of non diluted COVID Pfizer MRNA 6 months to 4 year old vaccine.
Age: 18.0
Sex: F
Vaccine: TDAP
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: NONE
Age: 13.0
Sex: F
Vaccine: TDAP
Symptoms: Dizziness, Fall, Head injury, Lip pain, Syncope
Clinical narrative: Patient received vaccine, along with HPV and Meningococcal.  Shortly after receiving dose she stood to leave became syncopal falling and striking head on upper right side.  Patient was completely unresponsive for approx 30 seconds.  At that time she became aware of surrounding stating that she felt dizzy.  RN Case manager asks if patient had eaten today,  patient states that she had not eaten today.  Patient states that her head, and lip was hurting.  Oxygen was applied EMS notified.  Patient left facility via gurney, accompanied with parent.
Age: 13.0
Sex: F
Vaccine: TDAP
Symptoms: Unresponsive to stimuli
Clinical narrative: Patient received vaccine, along with HPV and Meningococcal.  Shortly after receiving dose she stood to leave became syncopal falling and striking head on upper right side.  Patient was completely unresponsive for approx 30 seconds.  At that time she became aware of surrounding stating that she felt dizzy.  RN Case manager asks if patient had eaten today,  patient states that she had not eaten today.  Patient states that her head, and lip was hurting.  Oxygen was applied EMS notified.  Patient left facility via gurney, accompanied with parent.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age, Underdose
Clinical narrative: Patient received 5-11 year old instead of 12 years of age and older dosage.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Autoimmune disorder, Autoimmune thyroiditis, Autoimmune uveitis, Biopsy vulva abnormal, Eye pain
Clinical narrative: uveitis  of my only eye right and my ophthalmologist. In different location said I may need autoimmune suppressive therapy for life. After receiving the Moderna Vaccine in December 2020 I started having vision decreased and pain in right eye only eye I have and went to an ophthalmologist  in Jan-August 2021 treating and was diagnosed with Autoimmune Uveitis and put on steroid eye drops, then about  July 2021 saw an Endocrinologist and diagnosed with autoimmune disorder Hashimoto's (never had before COVID Vaccine) , and now in 2024 diagnoses with  Lichen  Sclerosus of Vulva and I am wondering if all these Aitoimmune issues started after taking the vaccine if they vaccine caused them
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Lichen sclerosus, Ultrasound scan abnormal, Visual impairment
Clinical narrative: uveitis  of my only eye right and my ophthalmologist. In different location said I may need autoimmune suppressive therapy for life. After receiving the Moderna Vaccine in December 2020 I started having vision decreased and pain in right eye only eye I have and went to an ophthalmologist  in Jan-August 2021 treating and was diagnosed with Autoimmune Uveitis and put on steroid eye drops, then about  July 2021 saw an Endocrinologist and diagnosed with autoimmune disorder Hashimoto's (never had before COVID Vaccine) , and now in 2024 diagnoses with  Lichen  Sclerosus of Vulva and I am wondering if all these Aitoimmune issues started after taking the vaccine if they vaccine caused them
Age: 16.0
Sex: F
Vaccine: HPV9, MENB, MNQ
Symptoms: Chest pain, Dizziness
Clinical narrative: Dizziness and chest pain.  Recovered fully after 15 minutes.
Age: 76.0
Sex: F
Vaccine: HEP
Symptoms: Product substitution error, Underdose
Clinical narrative: Patient was given pediatric dose (out of state count) versus adult dose (out of out adult count)
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash, Rash papular, Tenderness
Clinical narrative: Patient reports a rash occurring after vaccination first occurring about 1 week after 2nd dose. Received initial dose 10/24/2018 without issue. Rash is streaky and raised similar to a poison ivy rash and occurs only on the vaccinated arm. Has occurred approximately 5-6 times since vaccination, lasting around 2 days each times. Generally occurs on hot days. Patient reports tenderness to touch. Has not utilized any treatments, pharmaceutical or otherwise, aside from washing affected area with soap and water
Age: 67.0
Sex: F
Vaccine: UNK
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Malaise
Clinical narrative: Patient reported general feeling of unwellness and unbearable pain, swelling, and redness at injection site for 5 days after injection. Tried icing arm with little/no relief.
Age: 5.0
Sex: F
Vaccine: HEP, IPV, MMRV
Symptoms: Vomiting
Clinical narrative: About 15 minutes after vaccination client started vomiting
Age: 1.33
Sex: M
Vaccine: DTAP, HEPA, HIBV, MMR, PNC13, VARCEL
Symptoms: Gait disturbance, Injection site abscess, Injection site cellulitis, Injection site mass, Injection site pain
Clinical narrative: Dr seen patient 7/15/24 for follow up vaaccine administration. Dr reported " tender ball on irght thigh the next day after receiving vaccine. Ball continued to grow with patient limping at times due to pain." Md diagnosed patient woth cellulitis and abscess of te lower extremity, treating with antibiotics.
Age: 16.0
Sex: F
Vaccine: HPV9
Symptoms: Eye movement disorder, Seizure
Clinical narrative: Within seconds of injection, eyes roll back, brief tremor like seizures
Age: 40.0
Sex: F
Vaccine: TDAP
Symptoms: Diarrhoea, Fatigue, Gene mutation, Immunisation reaction, Migraine
Clinical narrative: Patient reports after receiving TD vaccine 7/11/2024 that 1 hour after vaccine "my entire arm went dead" and was down for 2 days, severe fatigue, migraine, nausea, diarrhea, full body aches. Provider note 7/12/24  Adverse effect of vaccine, initial encounter Localized reaction, does not appear to me allergic reaction Supportive care, ibuprofen,tylenol prn pain Ok to use arm as needed
Age: 40.0
Sex: F
Vaccine: TDAP
Symptoms: Musculoskeletal disorder, Nausea
Clinical narrative: Patient reports after receiving TD vaccine 7/11/2024 that 1 hour after vaccine "my entire arm went dead" and was down for 2 days, severe fatigue, migraine, nausea, diarrhea, full body aches. Provider note 7/12/24  Adverse effect of vaccine, initial encounter Localized reaction, does not appear to me allergic reaction Supportive care, ibuprofen,tylenol prn pain Ok to use arm as needed
Age: 4.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, No adverse event, Product preparation error
Clinical narrative: Pt recieved undilted 6mon-4 year vaccine. should have been diluted with 1.1ml NS. Pt had no adverse effect, just soreness in L arm following vaccines lasting 2 days.
Age: 20.0
Sex: M
Vaccine: HPV9, MNQ, TDAP
Symptoms: Muscle contractions involuntary, Mydriasis, Respiratory rate decreased
Clinical narrative: Administered Boostrix & Menveo in L arm first, followed by injection of Gardasil in R arm second.  Pt appeared relaxed during injection and made small talk during interaction. Seconds after injection of the 3rd vaccine (Gardasil) pt looked down, total body muscle contraction, dilated pupils, decreased respirations. Mother protected head as we lowered pt to a sitting position on the floor and EMS was called. Within a minute or two pt was breathing, pupils were returning to normal, and pt began responding to mother and myself talking to him. EMS arrived and evaluated pt having him stand and walk without difficulty. Pt and both parents declined transportation to the hospital for evaluation. Followed up with pt today (07/18/24). Mother reported no additional issues.
Age: 12.0
Sex: F
Vaccine: MENB
Symptoms: Wrong product administered
Clinical narrative: Patient's chart reviewed, and discovered patient was given Bexsero (Men B) instead of Menveo (ACYW) as indicated for her age. Vaccines were ordered in the EMR by the physician and given as directed by nursing staff. Resident physician was notified of the error and the family was promptly called. Patient's father was advised that while this vaccine is not contraindicated for her age, it is not recommended to be given until age 16-18 years old and that patient would need to return to clinic to receive Menveo as indicated. Family declined additional vaccinations at this time.
Age: 50.0
Sex: F
Vaccine: UNK
Symptoms: Hypoaesthesia, Mobility decreased, Musculoskeletal stiffness, Pain in extremity
Clinical narrative: Vaccine given on 7/11/24 arm was sore, was feeling better on 7/13 and on 7/14 increased pain, stiffness, numbness to upper arm, difficulty lifting arm which has persisted
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Injection site swelling, Paraesthesia
Clinical narrative: pt still has swelling  at injection site and tingling and numbness in left arm
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Crying, Fall, Syncope
Clinical narrative: Patient post administration of varicella vaccines about 10 mins after was observed with mom walking down the hallway looking for lobby was approached and while conversing with mom noted patient fainted and went down to the floor and got up and started crying and patient's mom stated that patient had not had any meal for the day. Patient was transferred to exam bed and stat call to provider for evaluation. Patient was examined and vital signs unremarkable. Observation and snacks were provided to patient . Patient was cleared for discharged by provider, ER precaution was given for any observed symptoms related to the incident.
Age: 65.0
Sex: F
Vaccine: TD, TDAP
Symptoms: Extra dose administered
Clinical narrative: Pt received  Td and Tdap at the same clinic but different locations. Pt was called and informed by out provider. Pt was informed to report to the clinic for any reactions. Pt agreed.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abscess intestinal, Ankle fracture, Calculus urinary, Central venous catheterisation, Computerised tomogram
Clinical narrative: Constant diarrhrea, between 10-90x a day, fall risk from diarrhrea - fall and broke ankle & wrist, developed Diverticulitis of small with perforation, Diverticulitis of large intestine with perforation and abscess without bleeding,, sepsis, developed IBD, IBS, periconolic stranding, Endocrine System Disease, Essential Thrombocythemia, Leukocytosis, Urolithiasis, Pelvic Inflammatory Disease, Aorta & Vascularity: Mild aortoiliac atherosclerosis (AIOD) a manifestation of peripheral arterial disease (PAD), (slowing down blood flow plaque from fatty) without aneurysm, 5 mm phlebolith anterior to psoas at level of L4, Heart: Mild Emphysematous, Liver: Mild Hepatic Steatosis  fatty liver, Crohn's Disease, Abnormal findin
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Crohn's disease, Diarrhoea, Diverticulitis intestinal perforated, Emphysema, Endocrine disorder
Clinical narrative: Constant diarrhrea, between 10-90x a day, fall risk from diarrhrea - fall and broke ankle & wrist, developed Diverticulitis of small with perforation, Diverticulitis of large intestine with perforation and abscess without bleeding,, sepsis, developed IBD, IBS, periconolic stranding, Endocrine System Disease, Essential Thrombocythemia, Leukocytosis, Urolithiasis, Pelvic Inflammatory Disease, Aorta & Vascularity: Mild aortoiliac atherosclerosis (AIOD) a manifestation of peripheral arterial disease (PAD), (slowing down blood flow plaque from fatty) without aneurysm, 5 mm phlebolith anterior to psoas at level of L4, Heart: Mild Emphysematous, Liver: Mild Hepatic Steatosis  fatty liver, Crohn's Disease, Abnormal findin
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Essential thrombocythaemia, Fall, Hepatic steatosis, Irritable bowel syndrome, Large intestine perforation
Clinical narrative: Constant diarrhrea, between 10-90x a day, fall risk from diarrhrea - fall and broke ankle & wrist, developed Diverticulitis of small with perforation, Diverticulitis of large intestine with perforation and abscess without bleeding,, sepsis, developed IBD, IBS, periconolic stranding, Endocrine System Disease, Essential Thrombocythemia, Leukocytosis, Urolithiasis, Pelvic Inflammatory Disease, Aorta & Vascularity: Mild aortoiliac atherosclerosis (AIOD) a manifestation of peripheral arterial disease (PAD), (slowing down blood flow plaque from fatty) without aneurysm, 5 mm phlebolith anterior to psoas at level of L4, Heart: Mild Emphysematous, Liver: Mild Hepatic Steatosis  fatty liver, Crohn's Disease, Abnormal findin